Aim: Anti-allergic activity by mast cell stabilization assay
References
- Sagar, S. M., & Sharma, R. P. (2021). Mast cell stabilization and allergic response modulation: A review. Journal of Pharmacology and Experimental Therapeutics, 376(3), 265-278.
- Khandelwal, K. R. (2010). Practical Pharmacognosy: Techniques and Experiments. Nirali Prakashan.
- Kaliner, M. A., & Austen, K. F. (2018). Mechanisms of mast cell degranulation. Immunology Today, 6(4), 125-130.
1. Objective
To evaluate the anti-allergic activity of a test compound by assessing its ability to stabilize mast cells and prevent degranulation.
2. Principle
Mast cells play a crucial role in allergic reactions by releasing histamine and other inflammatory mediators upon degranulation. Stabilization of mast cells prevents this degranulation, reducing histamine release and allergic responses. This assay evaluates the potential of a test compound to inhibit degranulation induced by an allergen or chemical stimulant such as compound 48/80.
3. Materials Required
- Animals: Healthy Wistar rats (150–200 g) or Swiss albino mice (20–30 g)
- Reagents and Chemicals:
- Compound 48/80 (Mast cell degranulating agent)
- Tyrode’s solution (pH 7.4)
- Test compound (plant extract, synthetic drug, or standard anti-allergic drug like sodium cromoglycate)
- Formaldehyde (10%)
- Toluidine blue stain (0.1%)
- Equipment:
- Centrifuge
- Hemocytometer
- Light microscope
- Microtubes and pipettes
4. Experimental Procedure
4.1. Collection and Isolation of Rat Peritoneal Mast Cells
- Euthanize the rat using a humane method (CO₂ asphyxiation or cervical dislocation).
- Inject 10 mL of pre-warmed Tyrode’s solution into the peritoneal cavity and massage gently for 5 minutes.
- Aspirate the peritoneal fluid using a syringe and transfer it to a centrifuge tube.
- Centrifuge at 1000 rpm for 5 minutes.
- Discard the supernatant and resuspend the pellet in fresh Tyrode’s solution.
- Count the mast cells using a hemocytometer and adjust to a suitable concentration.
4.2. Treatment Protocol
- Divide the isolated mast cells into the following groups:
Control group: Mast cells without any treatment.
Negative control: Mast cells treated with Compound 48/80 (1 μg/mL).
Test groups: Mast cells pre-treated with different concentrations of the test compound (10, 50, 100 μg/mL) followed by Compound 48/80.
Standard group: Mast cells pre-treated with sodium cromoglycate (10 μg/mL) before adding Compound 48/80.
- Incubate the samples at 37°C for 10–15 minutes.
4.3. Staining and Microscopic Examination
- Fix the cells with 10% formaldehyde for 10 minutes.
- Stain with 0.1% toluidine blue for 5 minutes.
- Wash with phosphate-buffered saline (PBS) and air-dry the slides.
- Observe under a light microscope (100X magnification) to assess mast cell degranulation.
5. Observations & Data Analysis
- Count the total and degranulated mast cells in at least five random fields per slide.
- Calculate the percentage of degranulated mast cells using the formula:
- Compare the degranulation percentage across different groups to assess mast cell stabilization.
Sample Data Table
| Group | Total Mast Cells | Degranulated Mast Cells | % Degranulation |
| Control | 100 | 5 | 5% |
| Compound 48/80 | 100 | 85 | 85% |
| Test Compound (10 µg/mL) | 100 | 65 | 65% |
| Test Compound (50 µg/mL) | 100 | 45 | 45% |
| Test Compound (100 µg/mL) | 100 | 30 | 30% |
| Sodium Cromoglycate | 100 | 20 | 20% |
6. Interpretation of Results
- A higher percentage of mast cell degranulation indicates poor stabilization.
- A lower percentage of degranulation suggests effective mast cell stabilization and potential anti-allergic activity of the test compound.
- The test compound should exhibit a dose-dependent reduction in degranulation.
7. Precautions
- Maintain sterile conditions throughout the experiment.
- Use freshly prepared Tyrode’s solution.
- Handle Compound 48/80 with care, as it is a potent mast cell degranulator.
- Ensure proper euthanasia and ethical handling of animals as per institutional guidelines.
8. Conclusion
This assay helps in screening potential anti-allergic agents based on their mast cell stabilization properties. A compound showing significant inhibition of mast cell degranulation can be considered for further pharmacological investigations in allergic disorders.
Visit to: Pharmacareerinsider.com